Publications by authors named "Ivan Nediyalkov Chakarski"
Article Synopsis
- Researchers studied if lower blood pressure targets, beyond usual recommendations, provide additional protection against end-stage renal disease in patients already on ACE inhibitors.
- In a randomized controlled trial, patients were divided into two groups: one receiving conventional blood pressure control and the other receiving intensified control with added medication (felodipine).
- After approximately 19 months, the study found no significant difference in progression to end-stage renal disease between the two groups, indicating that further lowering blood pressure did not offer extra benefits.
